Board of

Mr Matthew Grounds


Mr Grounds is Chief Executive Officer and Country Head of UBS Australasia (since May 2008).  Until May 2014 he also held the position of Head of Corporate Client Solutions, Asia Pacific and was a member of the UBS investment Bank Global Executive Committee.

With more than 25 years investment banking experience, Mr Grounds is one of Australia’s leading corporate advisers and has been responsible for a number of landmark transactions for major Australian and international companies.

UBS is one of the world’s leading financial firms, serving a discerning global client base. As an organization, it combines financial strength with an international culture that embraces change.

Mr Grounds is Chairman of the Victor Chang Cardiac Research Institute, a member of the University of New South Wales Council, a member of the Business Council of Australia and Director of the UBS Foundation. Mr Grounds graduated from the University of New South Wales and holds a degree in Commerce (Finance Major) and Law.

Mr David Craig

Deputy Chairman

Mr Craig joined the Victor Chang Board in 2007 and took over as Chair of the Victor Chang Institute’s Finance & Risk Committee in 2012. Since 2006 he has been the Chief Financial Officer of the Commonwealth Bank of Australia. Mr Craig has over 30 years of experience in financial management, strategy, mergers and acquisitions. His previous roles include:  Chief Financial Officer for Australand, Global Chief Financial Officer of PwC Consulting, and Chief Operations Officer and for 15 years Senior Audit Partner of PricewaterhouseCoopers Australasia.

 Mr Craig is President of the Financial Executives Institute of Australia, a Director of the Lendlease Group, and has also served as a Director of the Australian Gas Light Company.   

Prof Robert Graham

Executive Director

Professor Graham is the inaugural Executive Director of the Victor Chang Cardiac Research Institute, and a member of its Finance & Risk, Appeals, and Media and Communications Committees. He is the Des Renford Professor of Medicine, and Professor of Biotechnology and Biomolecular Science, University of New South Wales, and Professor (adjunct) of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Prof Graham is a Fellow of the Australian Academy of Science and the Australian Academy of Health & Medical Sciences, and foreign member, Royal Danish Academy of Sciences and Letters. He is a member of the American Association for Clinical Research, the American Society of Clinical Investigation and the American Heart Association, and a Life Member, Heart Foundation of Australia.

Professor Graham is head of the Cardiac Receptor Biology Laboratory at the Victor Chang Cardiac Research Institute

Mr Peter Allen

Mr Allen is an Executive Director and Chief Executive Officer of Scentre Group. Prior to the establishment of Scentre Group in 2014, Mr Allen was an Executive Director and Chief Financial Officer of Westfield Group. 

Mr Allen joined Westfield in 1996 and between 1998 and 2004 was Westfield’s CEO of the United Kingdom / Europe and responsible for establishing Westfield’s presence in the United Kingdom. 

Prior to joining Westfield, Mr Allen worked for Citibank in Melbourne, New York and London.  Mr Allen is Chairman of the Shopping Centre Council of Australia and a Director of the Victor Chang Cardiac Research Institute.   

Prof Terry Campbell


Professor Campbell joined the Victor Chang Board in 2013. He is the Head of the Department of Medicine at St Vincent’s Hospital, and Deputy Dean of Medicine, University of New South Wales. From 2003 to 2009 he served as Deputy Director of the Victor Chang Institute alongside Professor Richard Harvey. He also served as President of the Cardiac Society of Australia from 2000 to 2002.

Professor Campbell’s work has encompassed both basic laboratory research and clinical cardiology. He has published over 100 peer-reviewed papers in international journals, and has held competitive funding from both the National Health & Medical Research Council and National Heart Foundation.

In 2003 he was appointed as a Member of the Order of Australia (AM).

Mrs Louise Di Francesco

Mrs Di Francesco joined the Board in 2010 and is the Chair of its Appeals Committee. Mrs Di Francesco has worked in the media industry for more than 30 years, initially as a journalist, and for the past 22 years in media and corporate communications. 

She is a specialist in all areas of corporate media management, public relations, issues management and crisis management, and has worked on campaigns for AAPT, CeBIT, Mercedes Benz Australian Fashion Week, Alterian, Carbon Planet, Australand, Lend Lease, Multiplex, Colliers, Landcom and James Fairfax.   

Mrs Jennifer Doubell


Jennifer Doubell joined the Victor Chang Institute Board in 2014. She has worked in the not for profit sector for more than 30 years, initially as a social worker and criminologist, and for the past 24 years, in development and fundraising.  She is a specialist in fundraising and philanthropy, and not for profit management.

Jennifer is currently the Executive Director of the Peter MacCallum Cancer Foundation.  Previous roles include National Fundraising Director at the Heart Foundation, Director of Development and External Affairs at the University of Sydney and at the Australian Graduate School of Management, and Group Manager, at The Wesley Mission, Sydney. In total across her various senior management positions in a number of organisations she has helped raise in excess of $380 million. She is the recipient of many industry awards for her work.

Mr Hamish Douglass


Mr Douglass joined the Board in 2016. He is Co-Founder, Chief Executive Officer and Chief Investment Officer of Magellan Financial Group. Mr Douglass is the Lead Portfolio Manager of Magellan’s Global Equities Strategies and a member of Magellan’s Investment Committee. 

He was formerly Co-Head of Global Banking for Deutsche Bank AG in Australia and New Zealand, a member of the Foreign Investment Review Board, the Financial Literacy Board, the Australian Government’s Takeovers Panel, and the Forum of Young Global Leaders – World Economic Forum.   

Prof Leslie Field


Professor Field joined the Victor Chang Institute Board in 2009. He was appointed to his current position as Deputy Vice-Chancellor (Research) at the University of NSW in 2005. His main areas of research are organometallic chemistry, catalysis and NMR spectroscopy. 

He is the author of more than 200 scientific papers and 4 text books. He is the recipient of the Rennie Medal (1983); The Edgeworth David Medal (1986); The Organic Chemistry Medal (1992); the Centenary of Federation Medal (2003) and the RACI Leighton Medal (2010).

He was elected as a Fellow of the Australia Academy of Science in 1996 and appointed as a Member of the Order of Australia in 2011 for his services to Chemistry and to Higher Education. 

Mr Angelos Frangopoulos


Mr Frangopoulos joined the Victor Chang Institute Board in 2009. He is the Chief Executive Officer of Australian News Channel Pty Ltd the owner and operator of Sky News Australia and Sky News New Zealand.Before joining Australian News Channel, he held positions at British Sky Broadcasting, the Nine Network and Prime Television. 

Mr Frangopoulos is the Chairman of the Australia Day Council of NSW, a member of Charles Sturt University Council, a member of the Advisory Board of Macquarie University’s Centre for Media History and a Director of the Australian Subscription Television and Radio Association.

Mr John Kean


Mr Kean has been a member of the Victor Chang Institute Board since 2003. He is Executive Chairman of Pinpoint Pty Limited.

John also acts as an Independent Business Advisor and holds directorships in various businesses involved in marketing, finance, education, primary production, property and healthcare. In addition to serving as a director of the Victor Chang Institute, he chairs the Finance Committee and was an inaugural member of the Appeals Committee.

Mr Shangjin (Jin) Lin

Mr Shangjin (Jin) Lin is the Managing Director at Aqualand Projects Pty Ltd which he established in 2014.

Mr Lin has worked in the family property business, Shenglong, since 2007. He began his career with luxury residential developments and has extensive experience in both commercial and residential projects.

Driven by Mr Lin’s strong entrepreneurial instincts and clarity of vision, Aqualand has successfully acquired nine development sites in Sydney and built a diverse property portfolio of development opportunities with an estimated end value of circa AUD$5 billion.

The first project, Lindfield Village, was released to market in February 2015 followed in November 2015 by Aqualand’s flagship project, The REVY, located on Sydney’s prestigious Darling Island.

Mr Lin is actively involved in all aspects of the business from acquisition through to delivery. His commitment to ensuring Aqualand is synonymous with exceptional quality in both design and construction and the finest in customer care stands Aqualand apart from its many competitors.

Mr Lin is a Member of the Art Gallery of NSW, President’s Council and of the Victor Chang Cardiac Research Institute Board.

Mr Lin holds a Bachelor of Commerce from Macquarie University.

Dr Gary Weiss


Dr Weiss joined the Victor Chang Institute Board in 2009. He holds the degrees of LL.B (Hons) (Bachelor of Law) and LL.M (Master of Law with distinction), as well as a Doctor of Juridical Science (JSD) from Cornell University, New York. 

Dr Weiss is Chairman of Coats plc and Secure Parking Pty Ltd, an executive director of Ariadne Australia Limited and a director of other companies, including Premier Investments Limited, Ridley Corporation Ltd and The Centre for Independent Studies. 

Ms Jill Margo


Ms Margo joined the Victor Chang Institute Board in 2008. She is a medical journalist on The Australian Financial Review. She has won numerous international and national media awards, including two Walkleys and a Churchill Fellowship. 

Since 2000, she has been a member of working parties charged with developing clinical and consumer guidelines for the management of prostate cancer. In 2006 Jill was awarded an Order of Australia for services to journalism and cancer. She holds a BA (Honours) in English literature, is a best-selling author and

Ms Annabel Spring


Annabel Spring was the Group Executive of the Wealth Management Division of the Commonwealth Bank of Australia (CBA) from 2011 to 2017.

She was responsible for Colonial First State, Colonial First State Global Asset Management, Wealth Management Advice and CommInsure, and is a member of the Group Executive Committee.

Annabel joined CBA in 2009 as Group Head of Strategy where she was responsible for strategy, mergers and acquisitions, and government relations.

Before joining CBA, Annabel was Managing Director and Global Head of Firm Strategy and Execution at Morgan Stanley in New York. Annabel has worked in the USA, Asia and Australia.

Annabel is Deputy Co-Chair of the Financial Services Council (FSC), and Director of the Victor Chang Cardiac Research Institute. She is also a member of Chief Executive Women.

Annabel holds degrees with honours in Laws and Economics from the University of Sydney and a Masters of Business Administration from Harvard Business School, where she graduated as a George F. Baker Scholar.

Back To Top